Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Ropivacaine in Pancreatic Cancer Surgery
NCT04449289Phase 2Unknown
- Sponsor
- Institutul Regional de Gastroenterologie și Hepatologie Prof. Dr. Octavian Fodor
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine, ropivacaine hydrochloride liposomal suspension injection in pancreatic cancer (PC), sponsored by Institutul Regional de Gastroenterologie și Hepatologie Prof. Dr. Octavian Fodor. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineropivacaine hydrochloride liposomal suspension injection
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04449289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04449289.